LOADING
Tag: BioSpace
Evommune ends development of lead asset in chronic hives after mid-stage efficacy woes – BioSpace
June 30, 2026
Evommune ends development of lead asset in chronic hives after mid-stage efficacy woes BioSpace Source link
chat_bubble0 Comment
visibility20 Views
LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE) – BioSpace
September 19, 2025
LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE) BioSpace Source link
chat_bubble0 Comment
visibility105 Views
Sanofi’s Anti-OX40 Blocker Falls ‘Well Below Expectations’ in Phase III Eczema Study – BioSpace
September 5, 2025
Sanofi’s Anti-OX40 Blocker Falls ‘Well Below Expectations’ in Phase III Eczema Study BioSpace Source link
chat_bubble0 Comment
visibility101 Views
Nektar Declares Phase IIb Eczema Win for Rezpeg—But Analysts Unconvinced – BioSpace
June 25, 2025
Nektar Declares Phase IIb Eczema Win for Rezpeg—But Analysts Unconvinced BioSpace Source link
chat_bubble0 Comment
visibility126 Views